Gynecologic Oncology

The best-ranked hospitals for gynecology have once again been listed by U.S. News & World Report. We noticed a trend-observational only-and want to know what you think.

The optimal time to get the HPV vaccine is before a first sexual encounter. But getting the vaccine after still offers significant protection against cervical dysplasia.

An analysis of minimally invasive hysterectomies performed at multiple institutions over a 7-year period shows that one in every 368 women who underwent morcellation had uterine cancer. According to the investigators, the study also reveals an association between advanced age and increasing prevalence of underlying cancer and endometrial hyperplasia in these patients.

The morcellation controversy heats up as physicians all over the world who use Ethicon power morcellators are being asked to return the medical devices.

Spending on screening mammography has increased 44% ($296 million) in 8 years, without a corresponding increased benefit of earlier detection of breast cancer.

New recommendations against routine pelvic exams in adult women with no symptoms have been issued by the American College of Physicians. What do you think?

New minimally invasive robotic surgical techniques may offer some benefit to patients, but only once surgeons pass the learning curve.

Obstetricians agree they should have a role in reducing pregnant women’s exposure to environmental toxins, but most fail to discuss the subject with patients.

These simple tips can help pregnant patients reduce their exposure to environmental toxins and harmful chemicals, such as lead, mercury, BPA, and phthalates.

Breast tomosynthesis may be worth the extra cost to patients for breast cancer screening. Research shows the 3D technology finds more invasive cancers earlier.

This infographic reveals the breast cancer screening practices of fellow ObGyn.net readers. How do your recommendations compare with those of your colleagues?

Most older women with non-metastatic, estrogen-positive breast cancer initiate recommended treatment with an aromatase inhibitor or tamoxifen, research shows.

Drs Louise King, Camran Nezhat, and Paul Wetter discuss an effective teamwork model, agreeing that patients have better outcomes when clinicians work as a team.

Chemo after surgery for ovarian cancer is the standard of care, but new research discovers that many women, particularly older women, are undergoing chemo before surgery.

Institutions around the country have responded to an FDA advisory by discouraging or banning power morcellation of uterine fibroids. Innovative methods of contained morcellation are now called for.

The growing number of women who are opting for a double mastectomy after a cancer diagnosis suggests better education about the risk and benefits of the procedure is needed.

A new analysis of data from a nationwide hospital-based dataset shows that black women have higher odds of being diagnosed with triple-negative breast cancer-a subtype associated with poorer prognosis-than do white women, regardless of socioeconomic status (SES). The report was published in the June issue of Breast Cancer Research and Treatment.

According to a new study in Cancer, the incidence of cervical cancer in older women may be higher than has been previously reported.

The highest rates of cervical cancer occur in women aged 65 to 69, according to new estimates. This suggests that screening guidelines may need to be reconsidered.

Women who engage in vigorous physical activity before a diagnosis of ovarian cancer may be at lower risk of dying of the disease, according to a new report by investigators from the Women’s Health Initiative (WHI).

A false-positive mammogram result leaves women anxious, but new research shows that the anxiety is short-lived and may have an unintended beneficial effect.

Vaginal atrophy doesn’t have to be a life sentence of painful sex. New research describes a solution for dyspareunia that can take sex from “painful” to “comfortable.”

The FDA has weighed in on the safety of uterine fibroid morcellation. Given the current evidence, find out what they recommend.

The safety of fertility drugs has been a concern to physicians and patients alike. A new study assessing fertility drugs and breast cancer risk has reassuring results.

A recent study in Cancer Epidemiology, Biomarkers & Prevention indicates that the link between breast cancer and fertility drugs may not be as strong as previously suspected.